https://finance.yahoo.com/news/pfizer-why-its-fy2024-downgrade-has-wall-street-wary-195841679.html
0
0
32 words
0
Comments
Pfizer is facing more doubt and scrutiny as it lacks a blockbuster to fill its coffers after the pandemic boom subsides.
You are the first to view
Create an account or login to join the discussion